(Q68098851)

English

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

scientific article published on 01 January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

J A Wise

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

M B Mokyr

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

S Dray

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

191-197

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

https://scigraph.springernature.com/pub.10.1007/bf00205439

0 references

Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separation of mouse spleen cells by passage through columns of sephadex G-10

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-induced suppressor cells in mice: suppression of the antibody response in vitro and characterization of the effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/3263205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205439

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3263205%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68098851&oldid=1753288894"